Market Overview

Why Vaxart's Stock Is Trading Higher Today

Share:
Why Vaxart's Stock Is Trading Higher Today

Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target.

The company also raised about $90 million in gross proceeds through at-the-market-facility.

Vaxart is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally.

The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. Geographically all the business activity is functioned through the region of the US.

Vaxart shares were trading up 50.25% at $11.99 at the time of publication on Monday. The stock has a 52-week high of $14.30 and a 52-week low of 25 cents.

Latest Ratings for VXRT

DateFirmActionFromTo
Jul 2020B. Riley FBRInitiates Coverage OnBuy
Apr 2020HC Wainwright & Co.ReiteratesBuy
Jun 2019H.C. WainwrightInitiates Coverage OnBuy

View More Analyst Ratings for VXRT
View the Latest Analyst Ratings

 

Related Articles (VXRT)

View Comments and Join the Discussion!

Posted-In: why it's movingAnalyst Color Price Target Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
CHCTPiper SandlerMaintains55.0
BNFTPiper SandlerMaintains30.0
AFGPiper SandlerMaintains78.0
TASTStephens & Co.Maintains9.0
EPAMNeedhamMaintains350.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com